Literature DB >> 8089811

Integrin expression in squamous neoplasia of the cervix.

D E Hughes1, G Rebello, A al-Nafussi.   

Abstract

Epithelial cell-basement membrane interactions are important in maintaining tissue architecture and function, and the anatomical and functional relationships between epithelial cells and their basement membranes are clearly altered in malignancy. These interactions are thought to be largely mediated by the integrins, a family of heterodimeric transmembrane glycoproteins, each consisting of an alpha and a beta chain. Epithelial integrins mainly belong to the beta 1 (VLA) subfamily, which forms receptors for matrix macromolecules such as fibronectin, laminin, and collagen. There is evidence that integrin expression changes in some epithelial malignancies, possibly in relation to invasive potential. Integrin expression in cervical neoplasia was studied by immunohistochemical examination of prospectively collected colposcopic biopsies. Well-characterized monoclonal antibodies against beta 1-4, alpha 1-6, and alpha V integrins were used to examine normal, koilocytic, and dysplastic cervical squamous epithelium, and invasive squamous carcinoma. beta 1, beta 4, alpha 2, alpha 3, alpha 6, and alpha V were expressed by the basal layer of normal cervical squamous epithelium and by dysplastic cells in CIN (cervical intraepithelial neoplasia) 1 and 2, with none being lost and no new chains acquired. In CIN3, these integrins were either expressed throughout the ectocervical epithelium or restricted to the basal layer. In the latter cases, integrin expression was retained to a greater degree by dysplastic squamous epithelium within endocervical glands. These patterns could not be correlated with age or smear history in the cases examined. Patterns of integrin expression in neoplastic cervical epithelium therefore differ from those of normal cervical epithelium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089811     DOI: 10.1002/path.1711730205

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.

Authors:  S V Litvinov; W van Driel; C M van Rhijn; H A Bakker; H van Krieken; G J Fleuren; S O Warnaar
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 2.  Aetiology, pathogenesis, and pathology of cervical neoplasia.

Authors:  M J Arends; C H Buckley; M Wells
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

3.  Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia.

Authors:  Gábor Sobel; István Szabó; Csilla Páska; András Kiss; Ilona Kovalszky; Anna Kádár; Ferenc Paulin; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

4.  Abnormal expression of integrin alpha 6 beta 4 in cervical intraepithelial neoplasia.

Authors:  J D Aplin; S Dawson; M W Seif
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

5.  Integrin beta1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo.

Authors:  E C Brockbank; J Bridges; C J Marshall; E Sahai
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

6.  Integrative topological analysis of mass spectrometry data reveals molecular features with clinical relevance in esophageal squamous cell carcinoma.

Authors:  She-Gan Gao; Rui-Min Liu; Yun-Gang Zhao; Pei Wang; Douglas G Ward; Guang-Chao Wang; Xiang-Qian Guo; Juan Gu; Wan-Bin Niu; Tian Zhang; Ashley Martin; Zhi-Peng Guo; Xiao-Shan Feng; Yi-Jun Qi; Yuan-Fang Ma
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

7.  Targeting HPV-infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine.

Authors:  Rachel M Levine; Christina V Dinh; Michael A Harris; Efrosini Kokkoli
Journal:  Bioeng Transl Med       Date:  2016-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.